PharmaTher Announces Closing of CAD$10 Million Private Placement with Institutional Investors Post published:September 28, 2021 Post category:Press Release
BetterLife Files Patent for TD-0148A for Treatment of Cluster Headaches and Related Disorders Post published:September 27, 2021 Post category:Press Release
Delix Therapeutics Closes $70 Million Series A Financing to Advance Pipeline of Novel Psychoplastogen Therapeutics to Treat Brain Disorders Post published:September 27, 2021 Post category:Press Release
MINDCURE Launches “Desire Project” To Treat Female Hypoactive Sexual Desire Disorder With MDMA-Assisted Psychotherapy Post published:September 27, 2021 Post category:Press Release
PharmaTher Announces CAD$10 Million Private Placement With Institutional Investors Post published:September 24, 2021 Post category:Press Release
Levitee Labs Announces DTC Eligibility Approval Post published:September 24, 2021 Post category:Press Release
Awakn Life Sciences Acquires Exclusive Rights to MDMA Research from Imperial College London Post published:September 23, 2021 Post category:Press Release
Numinus Completes Acquisition of Neurology Centre of Toronto Post published:September 23, 2021 Post category:Press Release
Wake Network, Inc. Receives Certificate of Drug Registration for Microdose Formulation in Jamaica Post published:September 23, 2021 Post category:Press Release
MindMed and Liechti Lab Provide Results from their Psilocybin R&D Collaboration Post published:September 23, 2021 Post category:Press Release